Sleep medicine · 2025
Impact of sleep apnea on direct societal and healthcare expenses in elderly patients: A nationwide register-based case-control study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hashiba Mads, Christiansen Christine Benn, Ibsen Michael, Nielsen Sebastian Kinnberg, Suusgaard Jeppe, Kjellberg Jakob, Lamberts Morten Kjøbek, Jennum Poul J
Аннотация
BACKGROUND: The demographic shift toward an aging population in Western societies increases healthcare demands. Obstructive sleep apnea (OSA), frequently underdiagnosed, is associated with health consequences. However, its broader economic impact on welfare and healthcare systems is inadequately quantified.
OBJECTIVE: To examine the direct societal and healthcare-related expenses following a diagnosis of OSA in elderly individuals.
METHODS: In this nationwide, register-based case-control study, individuals aged ≥65 years diagnosed with OSA between 2002 and 2019 were identified and matched 1:4 to controls by age, sex, cohabitation status, and municipality. Societal costs were defined as income from employment and public transfers. Healthcare costs were assessed using national healthcare registries. All financial data was adjusted to 2020 values.
RESULTS: A total of 21,555 elderly with OSA (mean age 71 years, 29.1 % female) were included and matched to 86,212 controls. During the year of diagnosis, 11.8 % of cases were employed, whereas 76.3 % received public pension. Compared to controls, OSA patients had significantly lower employment income (€23,102 vs. €23,810; p < 0.001 prior to, and €4381 vs €4486 (p < 0.001 after diagnosis) and higher public transfers. Healthcare costs nearly doubled in the index year compared to the preceding year, resulting in a net cost difference of €5219 per patient-year (p < 0.001) CONCLUSIONS: Elderly patients with OSA incur substantially increased societal and healthcare-related costs compared to matched controls. Our findings underscore the need for early identification and treatment of OSA to potentially mitigate economic burden.
OBJECTIVE: To examine the direct societal and healthcare-related expenses following a diagnosis of OSA in elderly individuals.
METHODS: In this nationwide, register-based case-control study, individuals aged ≥65 years diagnosed with OSA between 2002 and 2019 were identified and matched 1:4 to controls by age, sex, cohabitation status, and municipality. Societal costs were defined as income from employment and public transfers. Healthcare costs were assessed using national healthcare registries. All financial data was adjusted to 2020 values.
RESULTS: A total of 21,555 elderly with OSA (mean age 71 years, 29.1 % female) were included and matched to 86,212 controls. During the year of diagnosis, 11.8 % of cases were employed, whereas 76.3 % received public pension. Compared to controls, OSA patients had significantly lower employment income (€23,102 vs. €23,810; p < 0.001 prior to, and €4381 vs €4486 (p < 0.001 after diagnosis) and higher public transfers. Healthcare costs nearly doubled in the index year compared to the preceding year, resulting in a net cost difference of €5219 per patient-year (p < 0.001) CONCLUSIONS: Elderly patients with OSA incur substantially increased societal and healthcare-related costs compared to matched controls. Our findings underscore the need for early identification and treatment of OSA to potentially mitigate economic burden.